Stem Cell Therapeutics Corp., of Calgary, Alberta, filed a final short-form base shelf prospectus with the securities commissions in British Columbia, Alberta, Manitoba, Ontario and Nova Scotia allowing the company to offer common shares, warrants or units for initial aggregate proceeds of up to $15 million during the next 25 months.